comparemela.com

Latest Breaking News On - Berger financial group inc - Page 8 : comparemela.com

Gladstone Institutional Advisory LLC Has $4.91 Million Stock Holdings in Goldman Sachs Innovate Equity ETF (NYSEARCA:GINN)

Gladstone Institutional Advisory LLC raised its stake in Goldman Sachs Innovate Equity ETF (NYSEARCA:GINN – Free Report) by 1.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 93,464 shares of the company’s stock after buying an additional 1,715 shares during […]

Motco Grows Stock Holdings in Abbott Laboratories (NYSE:ABT)

Motco lifted its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 32.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,422 shares of the healthcare product maker’s stock after purchasing an additional 350 shares during the period. Motco’s […]

Thoroughbred Financial Services LLC Grows Stake in Schwab US Large-Cap ETF (NYSEARCA:SCHX)

Thoroughbred Financial Services LLC lifted its holdings in shares of Schwab US Large-Cap ETF (NYSEARCA:SCHX – Free Report) by 2.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,971 shares of the company’s stock after buying an additional 675 shares during […]

Assetmark Inc. Purchases 246,499 Shares of Schwab US Large-Cap ETF (NYSEARCA:SCHX)

Assetmark Inc. grew its position in Schwab US Large-Cap ETF (NYSEARCA:SCHX – Free Report) by 20.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 1,427,987 shares of the company’s stock after acquiring an additional 246,499 shares during the period. Assetmark Inc. owned 0.22% of Schwab US Large-Cap […]

Abbott Laboratories (NYSE:ABT) Shares Sold by Dillon & Associates Inc.

Dillon & Associates Inc. decreased its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 192,406 shares of the healthcare product maker’s stock after selling 4,057 shares during the quarter. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.